[go: up one dir, main page]

DE60223694D1 - Pflaster zur behandlung von funktionsstörungen und störungen des nagelwachstums - Google Patents

Pflaster zur behandlung von funktionsstörungen und störungen des nagelwachstums

Info

Publication number
DE60223694D1
DE60223694D1 DE60223694T DE60223694T DE60223694D1 DE 60223694 D1 DE60223694 D1 DE 60223694D1 DE 60223694 T DE60223694 T DE 60223694T DE 60223694 T DE60223694 T DE 60223694T DE 60223694 D1 DE60223694 D1 DE 60223694D1
Authority
DE
Germany
Prior art keywords
plaster
failures
treatment
functional disorders
nail growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60223694T
Other languages
English (en)
Other versions
DE60223694T2 (de
Inventor
Rudy Susilo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Trommsdorff GmbH and Co KG
Original Assignee
Trommsdorff GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trommsdorff GmbH and Co KG filed Critical Trommsdorff GmbH and Co KG
Application granted granted Critical
Publication of DE60223694D1 publication Critical patent/DE60223694D1/de
Publication of DE60223694T2 publication Critical patent/DE60223694T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60223694T 2001-09-04 2002-09-04 Pflaster zur behandlung von funktionsstörungen und störungen des nagelwachstums Expired - Lifetime DE60223694T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01121202 2001-09-04
EP01121202 2001-09-04
PCT/EP2002/009912 WO2003020250A1 (en) 2001-09-04 2002-09-04 Plaster for the treatment of dysfunctions and disorders of nail growth

Publications (2)

Publication Number Publication Date
DE60223694D1 true DE60223694D1 (de) 2008-01-03
DE60223694T2 DE60223694T2 (de) 2008-10-30

Family

ID=8178546

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60223694T Expired - Lifetime DE60223694T2 (de) 2001-09-04 2002-09-04 Pflaster zur behandlung von funktionsstörungen und störungen des nagelwachstums

Country Status (22)

Country Link
US (1) US20040265362A1 (de)
EP (1) EP1423102B1 (de)
JP (1) JP4806162B2 (de)
KR (1) KR100757611B1 (de)
CN (1) CN1703206A (de)
AU (1) AU2002361825B2 (de)
BR (1) BR0212304A (de)
CA (1) CA2459483C (de)
CY (1) CY1107284T1 (de)
CZ (1) CZ301310B6 (de)
DE (1) DE60223694T2 (de)
DK (1) DK1423102T3 (de)
ES (1) ES2299630T3 (de)
IL (2) IL160550A0 (de)
MX (1) MXPA04001833A (de)
NO (1) NO20040936L (de)
NZ (1) NZ531406A (de)
PL (1) PL205576B1 (de)
PT (1) PT1423102E (de)
RU (1) RU2302857C2 (de)
WO (1) WO2003020250A1 (de)
ZA (1) ZA200401445B (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2459483C (en) * 2001-09-04 2009-06-23 Trommsdorff Gmbh & Co. Kg Arzneimittel Plaster for the treatment of dysfunctions and disorders of nail growth
US7615238B2 (en) * 2001-09-04 2009-11-10 Trommsdorff GmbH & Co. KG Arzneimitttel Plaster for the treatment of dysfunctions and disorders of nails, comprising sertaconazole
FR2867978B1 (fr) * 2004-03-29 2009-02-20 Galderma Res & Dev Patch d'amorolfine pour le traitement de l'onychomicose
FR2871692B1 (fr) * 2004-06-22 2007-08-03 Epitact Md Sa Procede et dispositif pour accelerer la croissance des phaneres, notamment des ongles
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
JP4992181B2 (ja) * 2004-12-28 2012-08-08 大正製薬株式会社 外用剤組成物
ES2557475T3 (es) 2005-06-17 2016-01-26 Vital Health Sciences Pty Ltd. Un portador que comprende uno o más derivados di- y/o monofosfato de agentes de transferencia de electrones
GT200600411A (es) * 2005-09-13 2007-05-21 Novartis Ag Combinaciones que comprenden un inhibidor del receptor del factor de crecimiento endotelial vascular
US8771726B2 (en) * 2006-08-28 2014-07-08 Hisamitsu Pharmaceutical Co., Inc Nail patch
WO2008105038A1 (ja) * 2007-02-23 2008-09-04 Nichiban Company Limited 抗真菌症用貼付剤
EP2207516A4 (de) * 2007-11-05 2013-02-13 Abigo Medical Ab Vorrichtung zur behandlung vaginaler pilzinfektionen
US8263115B2 (en) 2008-09-11 2012-09-11 Abigo Medical Ab Method and a product to reduce and treat problems associated with tinea pedis
US10893983B2 (en) 2008-12-03 2021-01-19 Abigo Medical Ab Method for dressing a wound
AU2010336441B2 (en) 2009-12-23 2015-02-05 Nuvo Research Inc. Highly permeating terbinafine formulation for treating onychomycosis
US10071030B2 (en) 2010-02-05 2018-09-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
JPWO2011096566A1 (ja) 2010-02-05 2013-06-13 久光製薬株式会社 爪白癬治療用貼付剤
MX2012010684A (es) 2010-03-17 2012-11-06 Novaliq Gmbh Composicion farmaceutica para el tratamiento de la presion intraocular incrementada.
ES2829386T3 (es) 2010-03-30 2021-05-31 Phosphagenics Ltd Parche de administración transdérmica
EP2462921A1 (de) 2010-11-11 2012-06-13 Novaliq GmbH Flüssige pharmazeutische Zusammensetzungen zur Behandlung einer Erkrankung der Hinterseite des Auges
EP2685992A4 (de) 2011-03-15 2014-09-10 Phosphagenics Ltd Aminochinoline als kinasehemmer
RU2483749C2 (ru) * 2011-04-15 2013-06-10 Леонид Леонидович Клопотенко Фармацевтическая композиция, содержащая инсулин и липосомы, для местного применения в виде биопленки
RU2483748C2 (ru) * 2011-04-15 2013-06-10 Леонид Леонидович Клопотенко Фармацевтическая композиция, содержащая инсулин и липосомы, для местного применения в виде пластыря
EP3192501B1 (de) 2011-05-25 2020-05-13 Novaliq GmbH Topische pharmazeutische zusammensetzung auf der basis von semifluorierten alkanen
WO2012160180A2 (en) * 2011-05-25 2012-11-29 Novaliq Gmbh Pharmaceutical composition for administration to nails
WO2013110621A1 (en) 2012-01-23 2013-08-01 Novaliq Gmbh Stabilised protein compositions based on semifluorinated alkanes
JP6039152B2 (ja) 2012-09-12 2016-12-07 ノバリック ゲーエムベーハー 半フッ素化アルカン組成物
BR112015004997B1 (pt) 2012-09-12 2022-09-13 Novaliq Gmbh Composições oftálmicas contendo misturas de alcanos semifluorados
CN114028560A (zh) 2013-07-23 2022-02-11 诺瓦利克有限责任公司 稳定的抗体组合物
CN110403923B (zh) 2015-09-30 2021-09-21 诺瓦利克有限责任公司 半氟化化合物和其组合物
WO2017055453A1 (en) 2015-09-30 2017-04-06 Novaliq Gmbh Semifluorinated compounds for ophthalmic administration
ES2981002T3 (es) 2015-12-09 2024-10-04 Avecho Biotechnology Ltd Formulación farmacéutica
PT3442480T (pt) 2016-06-23 2019-12-23 Novaliq Gmbh Método de administração tópica
EP3515420B1 (de) 2016-09-22 2023-11-08 Novaliq GmbH Pharmazeutische zusammensetzung zur verwendung in der therapie von blepharitis
AU2017329983B2 (en) 2016-09-23 2022-05-05 Novaliq Gmbh Ophthalmic compositions comprising ciclosporin
JP7198754B2 (ja) 2016-12-21 2023-01-04 アベーチョ バイオテクノロジー リミテッド 方法
BR112019012791A2 (pt) 2016-12-23 2019-12-03 Novaliq Gmbh composição oftálmica para o tratamento da doença do olho seco
CN110678207B (zh) 2017-04-21 2024-08-02 德马利克治疗公司 碘组合物
WO2018206656A1 (en) 2017-05-12 2018-11-15 Novaliq Gmbh Pharmaceutical compositions comprosing semifluorinated alkanes for the treatment of contact lense-related conditions
EP3687496A1 (de) 2017-09-27 2020-08-05 Novaliq GmbH Ophthalmische zusammensetzungen mit latanoprost zur verwendung in der behandlung von augenkrankheiten
CN120022260A (zh) 2017-10-04 2025-05-23 诺瓦利克有限责任公司 包含f6h8的眼用组合物
KR20200128407A (ko) 2018-03-02 2020-11-12 노바리크 게엠베하 네비볼롤을 포함하는 약제학적 조성물
CN112153970A (zh) 2018-04-27 2020-12-29 诺瓦利克有限责任公司 用于治疗青光眼的包含他氟前列素的眼用组合物
DE102018115270B4 (de) * 2018-06-26 2022-07-14 Vinederm GmbH Zubereitung als Gel und Pflaster zur topischen Behandlung von Haut- und/oder Nagelerkrankungen
KR102404412B1 (ko) 2018-09-27 2022-05-31 노바리크 게엠베하 국소 선스크린 제제
WO2020064549A1 (en) 2018-09-27 2020-04-02 Novaliq Gmbh Lipid barrier repair
WO2020074697A1 (en) 2018-10-12 2020-04-16 Novaliq Gmbh Ophthalmic composition for treatment of dry eye disease
RU2717086C1 (ru) * 2019-01-31 2020-03-18 Федеральное государственное бюджетное учреждение науки Ордена Трудового Красного Знамени Институт нефтехимического синтеза им. А.В. Топчиева Российской академии наук (ИНХС РАН) Способ получения основы для пластырей и гелей (варианты)
EP3923907B1 (de) 2019-02-13 2024-09-25 Novaliq GmbH Zusammensetzungen und verfahren zur behandlung von okularer neovaskularisation
RU2769437C1 (ru) * 2021-07-08 2022-03-31 Светлана Николаевна Абрамова Способ восстановления роста ногтя

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5181914A (en) * 1988-08-22 1993-01-26 Zook Gerald P Medicating device for nails and adjacent tissue
US5464610A (en) * 1992-10-15 1995-11-07 Schering-Plough Healthcare Products, Inc. Method for treating onychomycosis
RU2076754C1 (ru) * 1992-11-24 1997-04-10 Государственное научно-производственное предприятие "Исток" Способ лечения ониходистрофии
DE4337945A1 (de) * 1993-11-06 1995-05-11 Labtec Gmbh Pflaster zur Behandlung von Nagelmykosen
US5696164A (en) * 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
US5861142A (en) * 1996-03-25 1999-01-19 Schick; Mary Pichler Method for promoting hair, nail, and skin keratinization
JP2001502317A (ja) * 1996-10-16 2001-02-20 アイ・ピー・アール・インシティチュート・フォー・ファーマシューティカル・リサーチ・エー・ジー 新規なキャリヤー系
US6727401B1 (en) * 1998-02-12 2004-04-27 Watson Pharmaceuticals, Inc. Pressure sensitive adhesive matrix patch for the treatment of onychomycosis
AU5404399A (en) * 1998-09-10 2000-04-03 Ipr-Institute For Pharmaceutical Research Ag Topical application products
US6303140B1 (en) * 1999-10-13 2001-10-16 Schering-Plough Healthcare Products, Inc. Medicated device for warts, corns, calluses and nails
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
CA2459483C (en) * 2001-09-04 2009-06-23 Trommsdorff Gmbh & Co. Kg Arzneimittel Plaster for the treatment of dysfunctions and disorders of nail growth

Also Published As

Publication number Publication date
ES2299630T3 (es) 2008-06-01
ZA200401445B (en) 2005-03-10
EP1423102A1 (de) 2004-06-02
JP2005501885A (ja) 2005-01-20
IL160550A (en) 2010-11-30
MXPA04001833A (es) 2004-07-08
DE60223694T2 (de) 2008-10-30
EP1423102B1 (de) 2007-11-21
CA2459483A1 (en) 2003-03-13
WO2003020250A1 (en) 2003-03-13
NZ531406A (en) 2006-03-31
JP4806162B2 (ja) 2011-11-02
DK1423102T3 (da) 2008-04-14
CZ301310B6 (cs) 2010-01-13
BR0212304A (pt) 2004-10-13
PT1423102E (pt) 2008-02-25
KR20040031046A (ko) 2004-04-09
CA2459483C (en) 2009-06-23
CY1107284T1 (el) 2012-11-21
PL205576B1 (pl) 2010-05-31
US20040265362A1 (en) 2004-12-30
KR100757611B1 (ko) 2007-09-10
CZ2004317A3 (cs) 2004-10-13
AU2002361825B2 (en) 2007-01-25
CN1703206A (zh) 2005-11-30
IL160550A0 (en) 2004-07-25
RU2302857C2 (ru) 2007-07-20
NO20040936L (no) 2004-06-04
NO20040936D0 (no) 2004-03-03
RU2004106780A (ru) 2005-04-20
PL367513A1 (en) 2005-02-21

Similar Documents

Publication Publication Date Title
DE60223694D1 (de) Pflaster zur behandlung von funktionsstörungen und störungen des nagelwachstums
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
ATE286028T1 (de) Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
ATE293610T1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60239648D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Asthma
ATE293447T1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69936335D1 (de) Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
ATE369133T1 (de) Zur behandlung von schmerzen geeignete therapeutische mittel
DE60234760D1 (de) Phenylindole zur behandlung von hiv
ATE376444T1 (de) Ibandronsäure zur behandlung und vorbeugung von osteoporose
DE60208221D1 (de) Heterozyklische verbindungen zur behandlung von harnwegserkrankungen
DE60214542D1 (de) Verwendung von cox2 inhibitoren zur behandlung von schizophrenia und des ticks
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
ATE369130T1 (de) Carbamatverbindungen zur vorbeugung und behandlung von bewegungsstörungen
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
DE60236743D1 (de) Zur behandlung androgenabhängiger krankheiten
ATE337787T1 (de) Exemestan zur behandlung von hormonabhängigen störungen
DE60238765D1 (de) Carbamatverbindungen zur behandlung von schmerz
DE50114605D1 (de) No-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
ATE359783T1 (de) Aroylpyrrolheteroeryl und methanole zur behandlung von störungen des zentralnervensystems
ATE443060T1 (de) Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition